Search Results - "Rowe, C.C."

Bifidobacterium bifidum R0071 decreases stress-associated diarrhoea-related symptoms and self-reported stress: a secondary analysis of a randomised trial by Culpepper, T, Christman, M C, Nieves, Jr, C, Specht, G J, Rowe, C C, Spaiser, S J, Ford, A L, Dahl, W J, Girard, S A, Langkamp-Henken, B

“…Psychological stress is associated with gastrointestinal (GI) distress. This secondary analysis from a randomised, double-blind, placebo-controlled study…”
Get more information

81 In vivo tau imaging with PET by Villemagne, Victor L, Furumoto, S, Fodero-Tavoletti, M.T, Mulligan, R.S, Jones, G, Piguet, O, Hodges, J, Kudo, Y, Masters, C.L, Yanai, K, Rowe, C.C, Okamura, N

Get full text

IN54-TH-01 Biomarkers for Alzheimer's disease from large cohort studies by Milner, A, Ellis, K.A, Bush, A.I, Masters, C.L, De Fazio, D, Foster, J, Hudson, P, Lautenschlager, N.T, Lenzo, N, Martins, R.N, Pike, K, Rowe, C.C, Savage, G, Szoeke, C, Taddei, K, Villemagne, V.L, Woodward, M, Darby, D, Ames, D

Get full text

Prognostic serum miRNA biomarkers associated with Alzheimer’s disease shows concordance with neuropsychological and neuroimaging assessment by Cheng, L, Doecke, J D, Sharples, R A, Villemagne, V L, Fowler, C J, Rembach, A, Martins, R N, Rowe, C C, Macaulay, S L, Masters, C L, Hill, A F

“…There is no consensus for a blood-based test for the early diagnosis of Alzheimer’s disease (AD). Expression profiling of small non-coding RNA’s, microRNA…”
Get full text

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease by Lim, Y Y, Villemagne, V L, Laws, S M, Pietrzak, R H, Snyder, P J, Ames, D, Ellis, K A, Harrington, K, Rembach, A, Martins, R N, Rowe, C C, Masters, C L, Maruff, P

“…Accumulation of β-amyloid (Aβ) in the brain is associated with memory decline in healthy individuals as a prelude to Alzheimer’s disease (AD). Genetic factors…”
Get full text

Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition by CHETELAT, G, VILLEMAGNE, V. L, VILLAIN, N, JONES, G, ELLIS, K. A, AMES, D, MARTINS, R. N, MASTERS, C. L, ROWE, C. C

“…Given the recent and growing interest in the concepts of prodromal and presymptomatic Alzheimer disease, it is crucial to determine whether the presence of…”
Get full text

Dietary patterns and cognitive decline in an Australian study of ageing by Gardener, S L, Rainey-Smith, S R, Barnes, M B, Sohrabi, H R, Weinborn, M, Lim, Y Y, Harrington, K, Taddei, K, Gu, Y, Rembach, A, Szoeke, C, Ellis, K A, Masters, C L, Macaulay, S L, Rowe, C C, Ames, D, Keogh, J B, Scarmeas, N, Martins, R N

“…The aim of this paper was to investigate the association of three well-recognised dietary patterns with cognitive change over a 3-year period. Five hundred and…”
Get full text

Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing by Brown, B M, Peiffer, J J, Taddei, K, Lui, J K, Laws, S M, Gupta, V B, Taddei, T, Ward, V K, Rodrigues, M A, Burnham, S, Rainey-Smith, S R, Villemagne, V L, Bush, A, Ellis, K A, Masters, C L, Ames, D, Macaulay, S L, Szoeke, C, Rowe, C C, Martins, R N

“…Previous studies suggest physical activity improves cognition and lowers Alzheimer's disease (AD) risk. However, key AD pathogenic factors that are thought to…”
Get full text

Associations between gonadotropins, testosterone and β amyloid in men at risk of Alzheimer’s disease by Verdile, G, Laws, S M, Henley, D, Ames, D, Bush, A I, Ellis, K A, Faux, N G, Gupta, V B, Li, Q-X, Masters, C L, Pike, K E, Rowe, C C, Szoeke, C, Taddei, K, Villemagne, V L, Martins, R N

“…Testosterone and gonadotropins have been associated with cognitive decline in men and the modulation of β amyloid (Aβ) metabolism. The relatively few studies…”
Get full text

Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease by Villemagne, V.L., Pike, K.E., Darby, D., Maruff, P., Savage, G., Ng, S., Ackermann, U., Cowie, T.F., Currie, J., Chan, S.G., Jones, G., Tochon-Danguy, H., O’Keefe, G., Masters, C.L., Rowe, C.C.

“…Approximately 30% of healthy persons aged over 75 years show Aβ deposition at autopsy. It is postulated that this represents preclinical Alzheimer's disease…”
Get full text

A blood-based predictor for neocortical Aβ burden in Alzheimer’s disease: results from the AIBL study by Burnham, S C, Faux, N G, Wilson, W, Laws, S M, Ames, D, Bedo, J, Bush, A I, Doecke, J D, Ellis, K A, Head, R, Jones, G, Kiiveri, H, Martins, R N, Rembach, A, Rowe, C C, Salvado, O, Macaulay, S L, Masters, C L, Villemagne, V L

“…Dementia is a global epidemic with Alzheimer’s disease (AD) being the leading cause. Early identification of patients at risk of developing AD is now becoming…”
Get full text

Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease by YATES, P. A, SIRISRIRO, R, VILLEMAGNE, V. L, FARQUHARSON, S, MASTERS, C. L, ROWE, C. C

“…Incidental cerebral microhemorrhage (MH) is frequently found in older individuals scanned with susceptibility-weighted MRI (SWI) or gradient-recalled echo MRI…”
Get full text

Plasma apolipoprotein E and Alzheimer disease risk: The AIBL study of aging by GUPTA, V. B, LAWS, S. M, TADDEI, K, MARTINS, R. N, VILLEMAGNE, V. L, AMES, D, BUSH, A. I, ELLIS, K. A, LUI, J. K, MASTERS, C, ROWE, C. C, SZOEKE, C

“…There is mounting evidence for the contribution of apoE to the pathophysiology of Alzheimer disease (AD). Studies also indicate that plasma apoE levels may…”
Get full text

Cross-Sectional and Longitudinal Comparison of Tau Imaging with 18F-MK6240 and 18F-Flortaucipir in Populations Matched for Age, MMSE and Brain Beta-Amyloid Burden by Bourgeat, Pierrick, Krishnadas, N., Doré, V., Mulligan, R., Tyrrell, R., Bozinovski, S., Huang, K., Fripp, J., Villemagne, V. L., Rowe, C. C.

“…Objectives Longitudinal tau quantification may provide a useful marker of drug efficacy in clinical trials. Different tau PET tracers may have different…”
Get full text

Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer’s Disease using Cerebrospinal Fluid Biomarkers in the AIBL Study by Burnham, Samantha C., Coloma, P. M., Li, Q.-X., Collins, S., Savage, G., Laws, S., Doecke, J., Maruff, P., Martins, R. N., Ames, D., Rowe, C. C., Masters, C. L., Villemagne, V. L.

“…Background The National Institute on Aging and Alzheimer’s Association (NIA-AA) have proposed a new Research Framework: Towards a biological definition of…”
Get full text

Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum by Feizpour, A., Doré, V., Doecke, J. D., Saad, Z. S., Triana-Baltzer, G., Slemmon, R., Maruff, P., Krishnadas, N., Bourgeat, P., Huang, K., Fowler, C., Rainey-Smith, S. R., Bush, A. I., Ward, L., Robertson, J., Martins, R. N., Masters, C. L., Villemagne, V. L., Fripp, J., Kolb, H. C., Rowe, Christopher C.

“…Background Plasma p217+tau has shown high concordance with cerebrospinal fluid (CSF) and positron emission tomography (PET) measures of amyloid-β (Aβ) and tau…”
Get full text

Relationship between nicotinic receptors and cognitive function in early Alzheimer’s disease: A 2-[ 18F]fluoro-A-85380 PET study by Ellis, J.R., Villemagne, V.L., Nathan, P.J., Mulligan, R.S., Gong, S.J., Chan, J.G., Sachinidis, J., O’Keefe, G.J., Pathmaraj, K., Wesnes, K.A., Savage, G., Rowe, C.C.

“…Neuronal nicotinic acetylcholine receptors (nAChRs) are critical for higher order cognitive processes. Post-mortem studies suggest reductions in nAChRs…”
Get full text

The relationship between nicotinic receptors and cognitive functioning in healthy aging: An in vivo positron emission tomography (PET) study with 2-[18F]fluoro-A-85380 by Ellis, J.R., Nathan, P.J., Villemagne, V.L., Mulligan, R.S., Ellis, K.A., Tochon-Danguy, H.J., Chan, J.G., O'keefe, G.J., Bradley, J., Savage, G., Rowe, C.C.

“…Extensive experimental and neuropathological evidence supports the general hypothesis that decline in the basal forebrain cholinergic system contributes…”
Get full text

Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease by Villemagne, Victor L., Rowe, C.C., Macfarlane, S., Novakovic, K.E., Masters, C.L.

“…Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterised by the gradual onset of dementia. The pathological hallmarks of the disease…”
Get full text

II.P13 Amyloid load in Parkinson's Disease Dementia (PDD) and Lewy Body Dementia (LBD) measured with 11C-PIB PET by Edison, P., Rowe, C.C., Ahmed, I., Villemagne, V.L., Rinne, J., Brooks, D.J.

Get full text